Table 5.
Correlation of serum amyloid A and C-reactive protein levels among patients with various liver diseases
| Disease |
SAA (mg/L) |
CRP (mg/L) |
1Spearman’s rank correlation coeffi-cient | P value | ||
| mean ± SD | Median (minimum-maximum) | mean ± SD | Median (minimum-maximum) | |||
| CHB | 3.984 ± 4.743 | 3.250 (0.80-39.90) | 4.398 ± 6.522 | 1.500 (0.30-25.40) | 0.620 | < 0.001 |
| Autoimmune liver disease | 19.73 ± 24.81 | 13.70 (3.30-108.0) | 9.633 ± 5.977 | 9.100 (1.20-19.60) | 0.504 | 0.020 |
| Pyogenic liver abscess | 398.4 ± 246.8 | 413.5 (62.20-871.0) | 138.8 ± 57.46 | 141.1 (22.90-271.3) | 0.508 | 0.045 |
| Drug-induced liver injury | 8.036 ± 1.519 | 6.800 (3.40-26.20) | 6.490 ± 2.616 | 2.850 (0.30-25.30) | 0.219 | 0.544 |
1
The Spearman’s rank correlation test was used to determine correlation between groups. SAA: Serum amyloid A; CRP: C-reactive protein.